Forte Biosciences (FBRX) Short Interest Ratio & Short Volume → Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (From InvestorPlace) (Ad) Free FBRX Stock Alerts $0.71 -0.04 (-4.70%) (As of 11:50 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Forte Biosciences Short Interest DataCurrent Short Volume28,800 sharesPrevious Short Volume33,000 sharesChange Vs. Previous Month-12.73%Dollar Volume Sold Short$21,052.80Short Interest Ratio / Days to Cover1.0Last Record DateApril 30, 2024Outstanding Shares36,440,000 sharesPercentage of Shares Shorted0.08%Today's Trading Volume15,253 sharesAverage Trading Volume29,992 sharesToday's Volume Vs. Average51% Short Selling Forte Biosciences ? Sign up to receive the latest short interest report for Forte Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFBRX Short Interest Over TimeFBRX Days to Cover Over TimeFBRX Percentage of Float Shorted Over Time Ad InvestorPlaceYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI BreakthroughsWhile gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action Forte Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202428,800 shares $21,052.80 -12.7%N/A1 $0.73 4/15/202433,000 shares $23,430.00 -3.2%N/A1 $0.71 3/31/202434,100 shares $23,740.42 -19.2%N/A1 $0.70 3/15/202442,200 shares $26,164.00 -36.6%N/A1.2 $0.62 2/29/202466,600 shares $45,474.48 -17.2%N/A1.6 $0.68 2/15/202480,400 shares $55,910.16 +62.4%N/A2.1 $0.70 Get the Latest News and Ratings for FBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Forte Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/202449,500 shares $30,199.95 -28.7%N/A1.1 $0.61 1/15/202469,400 shares $51,356.00 -55.4%N/A1.8 $0.74 12/31/2023155,500 shares $127,774.35 +57.1%N/A3.9 $0.82 12/15/202399,000 shares $74,250.00 +40.4%N/A2.5 $0.75 11/30/202370,500 shares $33,417.00 +21.6%N/A1.7 $0.47 11/15/202358,000 shares $22,045.80 +3.2%N/A1.5 $0.38 10/31/202356,200 shares $27,594.20 -2.9%N/A1.8 $0.49 10/15/202357,900 shares $33,020.37 -10.9%N/A0.7 $0.57 9/30/202365,000 shares $43,030.00 -0.8%N/A0.8 $0.66 9/15/202365,500 shares $53,683.80 -1.8%N/A0.8 $0.82 8/31/202366,700 shares $55,367.67 -7.6%N/A0.8 $0.83 8/15/202372,200 shares $59,204.00 +38.3%N/A0.9 $0.82 7/31/202352,200 shares $52,722.00 -7.6%N/A0.7 $1.01 7/15/202356,500 shares $56,500.00 -0.9%N/A1.8 $1.00 6/30/202357,000 shares $59,280.00 +4.8%N/A0.9 $1.04 6/15/202354,400 shares $56,032.00 +0.4%N/A0.9 $1.03 5/31/202354,200 shares $55,284.00 -4.1%N/A0.8 $1.02 5/15/202356,500 shares $61,076.50 -15.7%N/A0.8 $1.08 4/30/202367,000 shares $71,690.00 -42.4%N/A1 $1.07 4/15/2023116,400 shares $125,712.00 +203.9%N/A1.7 $1.08 3/31/202338,300 shares $38,683.00 -27.3%N/A0.6 $1.01 3/15/202352,700 shares $51,999.09 -23.0%N/A1.3 $0.99 2/28/202368,400 shares $69,768.00 +0.4%N/A1.7 $1.02 2/15/202368,100 shares $68,100.00 -2.4%N/A1.7 $1.00 1/31/202369,800 shares $69,800.00 +0.7%N/A1.7 $1.00 1/15/202369,300 shares $70,686.00 -39.5%N/A1.7 $1.02 12/30/2022114,500 shares $114,500.00 +36.8%N/A2.8 $1.00 12/15/202283,700 shares $85,374.00 -16.3%N/A2.1 $1.02 11/30/2022100,000 shares $99,480.00 -19.4%N/A1.9 $0.99 11/15/2022124,100 shares $124,100.00 +17.1%N/A1.9 $1.00 10/31/2022106,000 shares $114,480.00 +1.7%N/A1.2 $1.08 10/15/2022104,200 shares $107,326.00 -10.8%N/A0.7 $1.03 9/30/2022116,800 shares $124,976.00 +8.4%N/A0.6 $1.07 9/15/2022107,800 shares $137,984.00 -2.3%N/A0.4 $1.28Elon Musk’s Next Move Will Disrupt AI Forever (Ad)A revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. FBRX Short Interest - Frequently Asked Questions What is Forte Biosciences' current short interest? Short interest is the volume of Forte Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 28,800 shares of FBRX short. Learn More on Forte Biosciences' current short interest. What is a good short interest ratio for Forte Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FBRX shares currently have a short interest ratio of 1.0. Learn More on Forte Biosciences's short interest ratio. Is Forte Biosciences' short interest increasing or decreasing? Forte Biosciences saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 28,800 shares, a decrease of 12.7% from the previous total of 33,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Forte Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Forte Biosciences: Iterum Therapeutics plc (7.68%), Biora Therapeutics, Inc. (4.52%), Oncternal Therapeutics, Inc. (0.49%), Lipocine Inc. (3.49%), Qilian International Holding Group Limited (0.69%), Unity Biotechnology, Inc. (2.16%), Lumos Pharma, Inc. (6.09%), Acasti Pharma Inc. (0.02%), Aprea Therapeutics, Inc. (1.90%), Lisata Therapeutics, Inc. (0.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Forte Biosciences stock? Short selling FBRX is an investing strategy that aims to generate trading profit from Forte Biosciences as its price is falling. FBRX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Forte Biosciences? A short squeeze for Forte Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FBRX, which in turn drives the price of the stock up even further. How often is Forte Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Iterum Therapeutics Short Squeeze Biora Therapeutics Short Squeeze Oncternal Therapeutics Short Squeeze Lipocine Short Squeeze Qilian International Holding Group Short Squeeze Unity Biotechnology Short Squeeze Lumos Pharma Short Squeeze Acasti Pharma Short Squeeze Aprea Therapeutics Short Squeeze Lisata Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FBRX) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsNext President (Not Trump. Not Biden.)The Freeport SocietyHave you heard of the $11 AI Coin?InvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold